Table 2.
Characteristics of survivors and non-survivors enrolled in the study.
| Non-Survivors (n = 31) | Survivors (n = 274) | P-value | ||
|---|---|---|---|---|
| Neonatal factor | GA (w) (median) [IQR] | 24.9 [23.5–26.4] | 27.7 [25.5–30.0] | <0.001 |
| BW (g) (median) [IQR] | 598 [534–830] | 937 [693–1,220] | <0.001 | |
| Male n (%) | 24 (77) | 130 (47) | 0.002 | |
| RDS n (%) | 17 (55) | 163 (59) | 0.618 | |
| SGA n (%) | 9 (29) | 48 (18) | 0.119 | |
| IVH n (%) | 7 (23) | 47 (17) | 0.453 | |
| BPD n (%) | 9 (30) | 61 (22) | <0.001 | |
| NEC n (%) | 4 (13) | 6 (2) | 0.001 | |
| Apgar Score (1 min) (median) [IQR] | 3 [2–5] | 5 [3–7] | <0.001 | |
| Apgar Score (5 min) (median) [IQR] | 6 [4–7] | 8 [6–8] | 0.001 | |
| Platelet counts (×104/μl) (median) [IQR] | 19.8 [13.3–26.9] | 20.9 [15.5–25.9] | 0.555 | |
| PCT (%) (median) [IQR] | 0.20 [0.14–0.26] | 0.20 [0.15–0.24] | 0.991 | |
| MPV (fl) (median) [IQR] | 10.5 [10.0–11.2] | 10.0 [9.2–10.5] | 0.001 | |
| PDW (%) (median) [IQR] | 12.2 [10.7–13.7] | 11.5 [10.4–13.9] | 0.275 | |
| PMI (fl nl−1) (median) [IQR] | 2,149 [1,438–2,632] | 2,028 [1,512–2,429] | 0.876 | |
| Maternal factor | PROM n (%) | 11 (35) | 64 (23) | 0.137 |
| CAM n (%) | 16 (52) | 91 (33) | 0.056 | |
| PA n (%) | 7 (23) | 28 (10) | 0.042 | |
| PIH n (%) | 6 (19) | 29 (11) | 0.146 | |
| HELLP n (%) | 2 (6) | 9 (3) | 0.370 | |
| GDM n (%) | 0 (0) | 7 (3) | 0.327 |
GA, gestational age; BW, birth weight; RDS, respiratory distress syndrome; SGA, small for gestational age; IVH, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; PCT, plateletcrit; MPV, mean platelet volume; PDW, platelet distribution width; PMI, Platelet mass index; PROM, preterm rupture of membranes; CAM, chorioamnionitis; PA, placental abruption; PIH, pregnancy-induced hypertension; HELLP, hemolysis, elevated liver enzymes, low platelets; GDM, gestational diabetes mellitus; IQR, interquartile range. Continuous variables are presented as medians.